Clinical Trials Browser

Phase 2 × Consolidation Chemotherapy × Clear all

NCT06162650 2026-04-08

Total Neoadjuvant Therapy in Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT03011528 2025-11-21

CombinaiR3

Phase 2 Completed

Neuroectodermal Tumors, Primitive, Peripheral

NCT05792735 2025-02-05

NeoCaCRT

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

NCT05274945 2022-03-11

Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

NCT05054959 2021-09-23

ICONA

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT04664504 2021-06-08

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

NCT00906841 2018-04-27

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

Phase 2 Terminated

Lymphoma, B-Cell

NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis